About
Andrew Lacy is a co-chair of Goodwin's Antitrust and Competition practice and a member of the firm's Life Sciences Disputes group. He advises on transaction-related antitrust risk, merger clearance, and represents clients before the FTC, DOJ, and state regulators.
Practice areas
AntitrustCompetitionMerger ControlClass ActionsLife SciencesLitigation
Office
Expertise
Life Sciences
Education
- JD, Georgetown University Law Center 2002
- BA, American University 1997